McClure Natalie
SVP, Product Development at Adamas Pharmaceuticals Inc
- Sold, on record
- $1.2M
- Dollars the filings state
- Form 4 sales
- 9
- Latest Apr 18, 2016
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Adamas Pharmaceuticals IncSVP, Product Development
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Adamas Pharmaceuticals IncUnusualDec 5, 2014 2014
Sold 2,000 shares at $14.01 ($28k)
McClure Natalie, SVP, Product Development
Sold 70.4% of holdings ($40k position)840 shares leftFiling
- 2 Form 4 sale Adamas Pharmaceuticals IncUnusualJan 5, 2015 +31 days
Sold 2,000 shares at $17.59 ($35k)
McClure Natalie, SVP, Product Development
Sold 70.4% of holdings ($50k position)840 shares leftFiling
- 3 Form 4 sale Adamas Pharmaceuticals IncUnusualFeb 5, 2015 +31 days
Sold 2,000 shares at $16.87 ($34k)
McClure Natalie, SVP, Product Development
Sold 70.4% of holdings ($48k position)840 shares left1x usual sizeFiling
- 4 Form 4 sale Adamas Pharmaceuticals IncUnusualMar 5, 2015 +28 days
Sold 2,000 shares at $17.15 ($34k)
McClure Natalie, SVP, Product Development
Sold 70.4% of holdings ($49k position)840 shares left1x usual sizeFiling
- 5 Form 4 sale Adamas Pharmaceuticals IncUnusualApr 6, 2015 +32 days
Sold 2,000 shares at $17.44 ($35k)
McClure Natalie, SVP, Product Development
Sold 70.4% of holdings ($50k position)840 shares left1x usual sizeFiling
- 6 Form 4 sale Adamas Pharmaceuticals IncUnusualMay 5, 2015 +29 days
Sold 2,000 shares at $17.62 ($35k)
McClure Natalie, SVP, Product Development
Sold 70.4% of holdings ($50k position)840 shares left1x usual sizeFiling
- 7 Form 4 sale Adamas Pharmaceuticals IncUnusualJun 5, 2015 +31 days
Sold 2,000 shares at $18.95 ($38k)
McClure Natalie, SVP, Product Development
Sold 70.4% of holdings ($54k position)840 shares left1x usual sizeFiling
- 8 Form 4 sale Adamas Pharmaceuticals IncUnusualApr 18, 2016 +318 days
Sold 36,000 shares at $18.50 ($666k)
McClure Natalie, SVP, Product Development
Sold 81.2% of holdings ($820k position)8,340 shares left18x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 18, 2016 | Apr 20, 2016 | Adamas Pharmaceuticals Inc | SVP, Product Development | Form 4 sale | 36,000 | $666k | 81.2% | Unusual | SEC |
| Jun 5, 2015 | Jun 9, 2015 | Adamas Pharmaceuticals Inc | SVP, Product Development | Form 4 sale | 2,000 | $38k | 70.4% | Unusual | SEC |
| May 5, 2015 | May 7, 2015 | Adamas Pharmaceuticals Inc | SVP, Product Development | Form 4 sale | 2,000 | $35k | 70.4% | Unusual | SEC |
| Apr 6, 2015 | Apr 7, 2015 | Adamas Pharmaceuticals Inc | SVP, Product Development | Form 4 sale | 2,000 | $35k | 70.4% | Unusual | SEC |
| Mar 5, 2015 | Mar 9, 2015 | Adamas Pharmaceuticals Inc | SVP, Product Development | Form 4 sale | 2,000 | $34k | 70.4% | Unusual | SEC |
| Feb 5, 2015 | Feb 6, 2015 | Adamas Pharmaceuticals Inc | SVP, Product Development | Form 4 sale | 2,000 | $34k | 70.4% | Unusual | SEC |
| Jan 5, 2015 | Jan 7, 2015 | Adamas Pharmaceuticals Inc | SVP, Product Development | Form 4 sale | 2,000 | $35k | 70.4% | Unusual | SEC |
| Dec 5, 2014 | Dec 9, 2014 | Adamas Pharmaceuticals Inc | SVP, Product Development | Form 4 sale | 2,000 | $28k | 70.4% | Unusual | SEC |
| Dec 1, 2014 | Dec 3, 2014 | Adamas Pharmaceuticals Inc | SVP, Product Development | Form 4 sale | 20,000 | $290k | 96.0% | Unusual | SEC |